The Clorox Company announced on January 22, 2026 that it has entered into a definitive agreement to acquire GOJO Industries, the maker of Purell, for $2.25 billion in cash. After anticipated tax benefits of approximately $330 million, the net purchase price is $1.92 billion. GOJO generated nearly $800 million in annual sales with a three-year compound annual growth rate of 5%, and its Purell brand holds the number one market share in hand sanitizer across both business-to-business and retail channels. GOJO’s installed base of roughly 20 million soap and sanitizer dispensers underpins recurring demand through a broad network of B2B distributors.

Clorox expects the acquisition to expand its Health and Wellness segment, leveraging GOJO’s market leadership and strong B2B relationships to accelerate consumer growth. The deal is accretive to Clorox’s long-term sales growth target of 3–5% and poised to generate at least $50 million in run-rate cost synergies. On a net of tax benefits basis, the transaction represents an adjusted EBITDA multiple of 11.9x, and 9.1x when including run-rate cost synergies. Clorox projects neutrality to adjusted EPS and EBITDA margin in the first year, with accretion to adjusted EPS in the second year following synergy realization.

Clorox plans to fund the acquisition primarily through debt financing and expects to complete the transaction before the end of its fiscal year 2026, subject to regulatory approvals and customary closing conditions. The company reaffirmed its fiscal 2026 outlook for net sales and adjusted EPS, excluding the impact of GOJO. Clorox engaged Centerview Partners LLC as financial advisor and Cooley LLP as legal advisor, while GOJO was advised by Harris Williams LLC and Jones Day. A live webcast discussion with CEO Linda Rendle and CFO Luc Bellet is scheduled for today at 2 p.m. PT.